Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


Calliditas Therapeutics Says First Patient In China Enrolled In Clinical Phase 3 Study NefIgArd With Nefecon


RTTNews | Sep 8, 2020 02:48AM EDT

02:47 Tuesday, September 8, 2020 (RTTNews) - Calliditas Therapeutics Says First Patient In China Enrolled In Clinical Phase 3 Study NefIgArd With Nefecon

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2020 RTTNews.com. All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC